Author: Dorron Blumberg
Palm Beach State College Executive Dean of the Belle Glade Campus Joins the Health Care District’s Hospital Advisory Board
Posted by Dorron Blumberg | Dec 4, 2019 | SF STAT! |
December 4 2019 – Dr. LaTanya L. McNeal, Executive Dean for Palm Beach State College’s Belle Glade campus, was recently appointed to the Lakeside Health Advisory Board, the Health Care District of Palm Beach County’s hospital advisory board. The board advises the Health Care District Board of Commissioners on issues related to the overall health and wellness of Glades residents, visitors and underserved members of the community. Dr. McNeal fills the seat vacated by Maria M. Vallejo, PhD who retired in March as Vice President for Growth & Expansion and Provost for the Palm Beach State College’s Belle Glade and Loxahatchee campuses.
Read MoreFIU biochemist searches for biomarkers to improve diagnosis and treatment of cancer, neurodegenerative diseases
Posted by Dorron Blumberg | Dec 4, 2019 | SF STAT! |
December 4, 2019 – The National Institute of General Medical Sciences has awarded FIU’s Biomolecular Sciences Institute $1.6 million to develop rapid diagnosis and improved treatment of cancer and neurodegenerative diseases, such as Alzheimer’s and Parkinson’s.
Read MoreWellington Regional Medical Center acquires additional 35 acres in Westlake for future medical campus – Land is adjacent to freestanding emergency medical facility that opened in April 2019
Posted by Dorron Blumberg | Dec 4, 2019 | SF STAT! |
Shekeab Jauhari, MD joins Florida Cancer Specialists as Drug Development Leader – Sarah Cannon Research Institute at FCS is expanding access to Phase 1 clinical research at new site in Lake Mary
Posted by Dorron Blumberg | Dec 3, 2019 | SF STAT! |
December 3, 2019 — Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the addition of Shekeab Jauhari, MD as a principal investigator on its research team. Dr. Jauhari is a medical oncologist/hematologist who will be leading Phase 1 clinical trials at the newest FCS Drug Development Unit in Lake Mary, FL, which is part of Sarah Cannon Research Institute (Sarah Cannon) and scheduled to open in early 2020. As a strategic research site for Sarah Cannon, one of the leading clinical research organizations in the world, FCS conducts clinical trials at more than 36 locations throughout the state.
Read MoreRecent Posts
-
-
-
Miami Jewish Health Names Alan Goldsmith PresidentNov 11, 2026 | SF STAT!
-
-












